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Antigens belonging to the Rh and Kell blood group systems are of 
major clinical significance because of their immunogenicity and 
the potential of their consequent antibodies to cause in vivo 
destruction of exogenous red blood cells (RBCs). Despite the wide-
spread use of transfusion, there are sparse data on the prevalence 
of Rh and Kell system antigens and their ethnic variability in 
Nigeria. The objective of this study was to determine the prevalence 
of the five major Rh (D, C, c, E, e) and Kell (K) system antigens in 
Nigeria with the goal of understanding alloimmunization risk in 
transfusion recipients and improving transfusion safety through 
the availability of resources, such as antisera for extended 
RBC typing and antigen panels for alloantibody detection. A 
multi-ethnic cohort of 302 healthy Nigerian individuals was 
created to study RBC antigen prevalence. The antigen status 
of these individuals for Rh and K antigens was determined 
using commercially prepared antisera and conventional tube 
agglutination methods. The prevalence of the Rh antigens in the 
study cohort was found to be: D (92.7%), C (20.5%), c (97.7%), E 
(19.5%), and e (97.4%). Dce was the most common Rh phenotype 
(53.3%). The prevalence of K was 0 percent. For all antigens, there 
was no association between ethnicity and antigen prevalence. This 
study is the first to document the prevalence of the major Rh and K 
antigens in the Nigerian population, using a multi-ethnic cohort. 
Serologic testing demonstrates a zero prevalence of K antigen, 
which has never been described. C and E pose the higher risks of 
alloimmunization, hence showing a need for extended RBC typing 
and matching in at-risk blood recipients. This study demonstrates 
that phenotyping for major Rh and K antigens within the Nigerian 
population can potentially improve transfusion safety and prevent 
alloimmunization. Immunohematology 2018;34:61–65.
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The clinical importance of any blood group antigen is 
determined by its ability to induce antibody formation and the 
ability of these antibodies to cause in vivo destruction of red 
blood cells (RBCs). Of the blood group antigens, the Rh and 
Kell antigens are particularly clinically significant because of 
their immunogenicity, high risk of alloantibody formation,1 
and ability to cause severe hemolytic transfusion reactions.2 
In many well-developed countries, such as the United States, 
the prevalence of RBC antigens and their ethnic variation are 
well established. In such countries, high-risk patients (such as 
those requiring frequent transfusion) are often preemptively 
matched for Rh and Kell system antigens in an effort to 
decrease the risk of alloimmunization. Unfortunately, this 
practice is impossible in developing countries such as Nigeria. 
In these areas with limited resources, antibody screening and 
RBC phenotyping are not routinely available. Because of the 
unavailability of testing, data on the prevalence and ethnic 
variation of the Rh and Kell antigen systems in Nigeria are 
very limited. This lack of data is especially problematic in sub-
Saharan African countries, where sickle cell disease is highly 
prevalent and RBC transfusion is a mainstay of therapy.3 In 
an effort to improve transfusion safety both in Nigeria and for 
black individuals worldwide with shared African ancestry, we 
conducted a study to determine the phenotypic distribution of 
the major Rh and K antigens in Nigeria.
Materials and Methods
Clinical Data
This study was community-based, analytical, and cross-
sectional. With ethics clearance from the University of Benin 
Teaching Hospital ethics and research committee, volunteers 
were recruited for this study (Protocol no. ADM/E22/A/VOl.
VII/1034). Only healthy Nigerian citizens were included. 
Exclusion criteria included a history of transfusion in the 
preceding 3 months, a history of hematologic malignancy, a 
history of autoimmune disease, and non-Nigerian citizenship. 
After informed consent was obtained, all participants under-
went a confidential interviewer-administered survey to 
document baseline demographics.
Serologic Testing
With informed consent, 3 mL blood was collected from 
each participant (N = 302) by antecubital venipuncture for 
antigen typing. The EDTA anticoagulated blood specimens were 
tested within 2 days of collection if stored at room temperature 
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(20–25°C) or within 14 days of sample collection if stored at 
a temperature of 1–6°C. Rh and K antigen typing was carried 
out using the conventional tube agglutination method and 
commercially sourced antisera according to the manufacturer’s 
instructions (Lorne Laboratories, Reading, UK). Each batch of 
tests was accompanied with control samples. Positive control 
cells were RBCs with single-dose antigen expression (i.e., 
C+c+ or E+e+). Negative control cells were RBCs that lacked 
the target antigens. All serologic reactions were carried out at 
optimal temperature (the temperature of the water bath was 
quality controlled with an external, calibrated thermometer). 
All centrifugations were performed at 1000 relative centrifugal 
force (RCF) for 20 seconds or suitable alternate force and time. 
Before reading each test after centrifugation, the tube was 
shaken gently to dislodge the RBC button from the bottom of 
the tube. All antisera were stored at 2–8°C when not in use.
Statistical Analysis
Of the Rh and Kell antigens studied, the antigen with 
the lowest prevalence is K, with a reported prevalence of 2 
percent for black individuals in the United States.4 Assuming 
the percentage of each antigen in Nigeria is 2 percent, sample 
size was calculated. For 80 percent power, two-sided alpha 
of 5 percent, to detect a difference of 0.05 (P1 – P0), with 
population proportion of 2 percent under null, a sample of 
96 was required. Data were inputted and analyzed using 
Statistical Package for Social Sciences (SPSS) version 16 (IBM, 
Armonk, NY). Variations in distributions of the blood group 
antigens were tested with the χ2 test or Fisher’s exact test, as 
appropriate. Probability value of less than 5 percent (p = 0.05) 
was considered statistically significant.
Results
Patient Demographics
Between January and April 2015, 302 healthy individuals 
were recruited from the University of Benin for the study of 
RBC antigens in the Nigerian population. Demographics 
of study participants (N = 302) are shown in Table 1. Mean 
age was 22.8 ± 3.3 years, and participants were primarily 
male (63.3%). The majority of the study cohort (77.2%) was 
composed of individuals from five major ethnic groups in 
Southern Nigeria, with Bini being the predominant ethnic 
group in the study population (27.5%). Representatives from 
26 other Nigerian ethnic groups constituted 22.8 percent of 
the study cohorts, with less than 10 individuals from each 
group.
Antigen Typing
Rh antigen typing was completed for all participants (N = 
302) using the manual tube testing method. As seen in Figure 
1, the prevalence of the five major Rh antigens in our study 
cohort were consistent with what is reported for the black 
population in the United States.4 The vast majority typed 
positive for D, c, and e. Only about 20 percent of our sample 
tested positive for C and E. Serologic testing demonstrated that 
no individuals in our cohort typed positive for K.
Building on results from serologic testing, Rh antigen 
phenotypes were determined. Because genotyping was 
not done, possible and most probable Rh phenotypes 
were determined (Table 2). Nine probable Rh phenotypes 
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Table 1. Demographics of study participants, N = 302
Number (%)
Age, years 16–25 256 (84.8)
26–35 44 (14.6)
36–45 2 (0.7)
Gender Male 191 (63.3)
Female 111 (36.8)






* Other ethnicities included Ika, Owan, Etsako, Isoko, Igala, Itsekiri, Ebira, 
Akoko-Edo, Ibibio, Ilaje, Igbanke, Ogori, Oron, Obolo, Ora, Ukuani, Jaba, 
Okpe, Nupe, Afemai, Bete, Idoma, Ijaw, Tiv, Enuani, and Mwaghavul.
Fig. 1 Rh and Kell antigen prevalence. Rh and Kell (K) antigen typings 
were completed using specific antisera and tube agglutination 
method for all participants in the study cohort (N = 302). Number 
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were identified in our study cohort. The most common Rh 
phenotype was Dccee (53.3%).
No statistically significant difference (p > 0.05) was 
observed in antigen prevalence among the studied ethnic 
groups in Nigeria (Table 3). Among the studied antigens, the 
probabilities of antigen-mismatched transfusions are highest 
for C and E (Table 4).
Discussion
Our study is the first to systematically determine the 
prevalence of the five major Rh and Kell (K) antigens in a 
multi-ethnic cohort from Nigeria. The prevalence of the D 
antigen in discrete parts of Nigeria has been well described, 
ranging from 93.9 percent5 to 98.8 percent,6 whereas the 
prevalence of the other four major Rh antigens in Nigeria is not 
well known. Prior studies on Rh antigen prevalence in Nigeria 
have been limited because they never effectively reflected the 
multi-ethnic makeup of Nigeria,7,8 which is a critical factor in 
determining the distribution of the Rh antigens.9 In contrast, 
our study benefited from the diverse ethnic background of our 
cohort, which included individuals from more than 30 ethnic 
groups (Table 1). In our study, the distribution of Rh antigens 
was consistent with what is reported for black individuals in 
the United States (Fig. 1).10
Rh phenotyping was also in agreement with what 
is reported for the black population in the United States 
(Table 2). Table 5 highlights data from previous studies on Rh 
antigen distribution in Port Harcourt and Calabar, Nigeria. 
Significant differences are observed in the distribution of the 
Rh antigens from Calabar and Port Harcourt, when compared 
with the index study and U.S. black individuals.7,8 This finding 
is somewhat surprising, since there was no multi-ethnic 
variations observed in the index study. A wider and larger 
sample size would be more representative and conclusive. 
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Table 2. Rh and Kell antigen phenotypes possible and most 
probable Rh genotypes, N = 302




D+,–,–,E–e+ (D–,–ee) 3 (1) *
D+,–,–,E+e+ (D–,–Ee) 1 (0.3) *
D+C–c+,–,– (Dcc–,–) 3 (1) *
Dce 161 (53.3) R0R0, R0r R0R0
DcEe 46 (15.2) R0R2, R2r, R0r´´ R0R2
DcE 5 (1.7) R2R2, R2r´´ R2R2
DCce 51 (16.9) R1R0, R0r ,́ R1r´ R0r’
DCcEe 7 (2.3) RzR0, R1R2, R1r´ ,́ 
R2r ,́ R0ry, Rzr
R0ry
DCe 3 (1) R1R1, R1r´ R1R1
Dce 20 (6.6) R0r R0r
dcEe 1 (0.3) r´´r r´´r




*Antithetical deletion of antigens present.












Other Edo  
(n = 21)
All Others  
(n = 48) p
D POS 75 16 68 22 35 18 46 0.387
NEG 8 2 2 3 2 3 2
C POS 16 3 17 6 9 2 9 0.807
NEG 67 15 53 19 28 19 39
c POS 79 17 70 24 37 21 47 0.371
NEG 4 1 0 1 0 0 1
E POS 16 3 13 1 11 5 10 0.348
NEG 67 15 57 24 26 16 38
e POS 82 18 67 24 35 21 47 0.706
NEG 1 0 3 1 2 0 1
K POS — — — — — — — —
NEG 83 18 70 25 37 21 48
POS = positive; NEG = negative.
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Possible variations resulting from differences in study 
populations and ethnicity cannot be completely excluded. It is 
worth noting that the Rhnull phenotype was not observed in 
this study. It is also worthy to note that no rr individuals were 
found in this study despite its ample sample size. Dccee is the 
most common Rh phenotype (53.3%) in our cohort (Table 2). 
In white individuals, the prevalence of the haplotypes from 
the most common to the least common is R1, r, R2, R0, r ,́ r´́ , 
Rz, and ry.14 In black individuals, the most common to the 
least common haplotype is R0, r, R1, R2, r ,́ r´́ , Rz, and ry.14 
Determining the most probable genotype depends on the 
knowledge of the frequency at which a particular antigenic 
combination derives from a single gene complex within a 
particular population. We observed R0ry (2.3%) to be slightly 
more common than R1R1 (1%) based on deductions of the most 
probable genotype, which appears inconsistent with the U.S. 
black population.4 Furthermore, the full Rh phenotype could 
not be characterized in seven (2.3%) participants (Table 2), 
most likely because of antithetical deletion of these antigens. 
Future efforts at genotyping would help in elucidating the gray 
areas and their underlying mechanism(s).
Unlike the Rh antigens, there are minimal reports on the 
distribution of K in Nigeria and no reports on the prevalence 
of other clinically significant Kell antigens. In our study 
cohort, no participants were positive for K. This finding is 
in agreement with the two existing studies of K in Nigeria 
(reported prevalence of 1%15 to 2%12,13) and what is reported for 
black populations in the United States. Notably, in our study 
cohort, the prevalence of all RBC antigens was not statistically 
correlated with ethnicity. Perhaps a large multicenter-based 
study will help to establish a better ethnic homogeneity and 
a sizeable study size to confirm or refute ethnic variability of 
these antigens.
Current practice in Nigeria does not include alloantibody 
screening or RBC phenotyping beyond D, even in at-risk blood 
recipients who require frequent transfusion. Such individuals 
include patients with sickle cell disease; multiparous women; 
and individuals with refractory anemia, myelodysplastic 
syndrome, or myelofibrosis and other clinical conditions 
associated with some form of transfusion dependence. In 
particular, sickle cell disease presents a huge burden, affecting 
at least 2 percent of the over 180 million Nigerian population.3 
Extended RBC typing will ensure provision of high-quality 
blood components and reduce the rate of alloimmunization 
among at-risk individuals. The national transfusion service 
in Nigeria lacks cohesiveness over the regional and state 
transfusion mechanisms. Uncommon antisera for extended 
RBC typing and cell panels for antibody identification are 
not routinely available. There is no reference transfusion 
laboratory. There are no data on hemovigilance reporting.
Theoretically, the risk of Rh alloimmunization in Nigeria 
was highest for C and E antigens. Available literature also 
suggests these Rh antigens are implicated in recipient 
alloimmunization in Nigeria.16–18 At a minimum, these authors 
recommend extended RBC typing and matching in at-risk 
blood recipients for at least C and E, particularly for patients 
with sickle cell disease. Optimal transfusion service delivery 
would require more robust data on Kell antigens (particularly K, 
k, Kpa, Kpb, Jsa, and Jsb), as studies also suggest that antibodies 
to Kell antigens may not be an uncommon occurrence in 
Nigeria.16–18 This knowledge is critical in managing patients, 
since it informs prediction of alloantibodies and selection of 
antigen-negative units.
We acknowledge that future studies with an expanded 
cohort are needed to confirm our findings. This expanded 
cohort could serve as a local donor data bank, a resource for 
providing compatible blood and for preparing indigenous RBC 
panels. Ultimately, our study constitutes the first description 
Table 4. Probabilities of antigen-mismatched transfusions in the 
study population, N = 302
Antigen Positive (%) Negative (%) Probability (%)
Rh system D 92.7 7.3 8.6
C 20.5 79.5 16.3
c 97.7 2.3 2.2
E 19.5 80.5 15.7
e 97.4 2.6 2.5
Kell system K — 100 0
Table 5. Comparison of prevalence of Rh and Kell antigens from 
other studies
Blood group antigen (%)
Reference D C c E e K
Index study 92.7 20.5 97.7 19.5 97.4 0
U.S. black 
population4
92 27 96 22 98 2
Port Harcourt, 
Nigeria7
89.0 24.3 82.0 20.1 54.0 —
Calabar, Nigeria8 94.44 2.78 100 18.89 95.56 —
Sokoto, Nigeria11 — — 92.0 - 98.5 —
Port Harcourt, 
Nigeria12
— — — — — 2
Sokoto, Nigeria13 — — — — — 2
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of Rh and K antigens in Nigeria, using a multi-ethnic cohort 
to reflect the heterogeneous population of Nigeria. These 
findings are applicable to black populations worldwide with 
shared African ancestry.
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